neffy® (epinephrine nasal spray) Approved in Canada as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis)

neffy offers a new delivery method for epinephrine in Canada for adults and children (>30 kg) living with severe allergic reactions

ALK- Abelló A/S, which licenses the rights to market neffy in Canada, expects availability in the summer of 2026

SAN DIEGO, April 15, 2026 (GLOBE NEWSWIRE) — ARS Pharmaceuticals, Inc.